EARNINGS AND TRADING: Scancell gets FDA clearance for phase 3 trial
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 0.21p on 12-02-2026 at 05:12:33 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.22p |
| Sell | 0.20p |
| Last Trade: | Sell 55,800.00 at 0.20p |
| Day's Volume: | 0 |
| Last Close: | 0.21p |
| Open: | 0.00p |
| ISIN: | GB00BSVYN304 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 0.18p - 1.00p |
| Market Capitalisation: | £4.51m |
| VWAP: | 0.00p |
| Shares in Issue: | 2.15b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 55,800 | 0.20p | Ordinary |
14:35:53 - 11-Feb-26 |
| Sell* | 45,407 | 0.201p | Ordinary |
11:48:19 - 11-Feb-26 |
| Sell* | 95,823 | 0.201p | Ordinary |
08:03:11 - 11-Feb-26 |
| Buy* | 9,090 | 0.22p | SI Trade |
16:15:36 - 10-Feb-26 |
| Buy* | 836 | 0.22p | SI Trade |
16:15:36 - 10-Feb-26 |
| Buy* | 3,000 | 0.22p | SI Trade |
16:15:36 - 10-Feb-26 |
| Sell* | 4,545 | 0.20p | SI Trade |
16:15:36 - 10-Feb-26 |
| Sell* | 10,000 | 0.20p | SI Trade |
16:15:36 - 10-Feb-26 |
| Sell* | 234,691 | 0.209p | Negotiated Trade |
15:55:36 - 10-Feb-26 |
| Sell* | 6,283 | 0.201p | Ordinary |
11:37:31 - 09-Feb-26 |
Theracryf PLC (TCF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Jan 2026 7:00 am | RNS | Ox-1 Addiction Programme Update |
| 5th Jan 2026 7:00 am | RNS | Key Ox-1 milestone & notice of investor webinar |
| 18th Dec 2025 7:00 am | RNS-R | Potential of Preclinical Program in Mental Fatigue |
| 3rd Dec 2025 7:00 am | RNS | Half-year Financial Report |
| 26th Nov 2025 7:00 am | RNS-R | Marking Addiction Awareness Week |
| 24th Nov 2025 7:00 am | RNS | Notice of Results |
| 3rd Nov 2025 7:00 am | RNS | Ox-1 Programme Achieves Manufacturing Milestone |
| 16th Oct 2025 4:45 pm | RNS | Holding(s) in Company |
| 16th Oct 2025 4:45 pm | RNS | Director/PDMR Shareholding |
| 10th Oct 2025 7:00 am | RNS-R | World Mental Health Day & Q4 Conference Schedule |